Evidence map›Paper›PMID 32193374›Full record

ArticleNature communications2020

FAM13A affects body fat distribution and adipocyte function.

Mohsen Fathzadeh, Jiehan Li, Abhiram Rao, Naomi Cook, Indumathi Chennamsetty, Marcus Seldin, Xiang Zhou, Panjamaporn Sangwung, Michael J Gloudemans, Mark Keller and 15 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Cells · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Long Story Short: Understanding Isoform-Specific Expression ofAmerican journal of respiratory cell and molecular biology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 4 countries.

Mohsen Fathzadeh *Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-7962-9148
Jiehan Li *Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Abhiram Rao *Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Naomi CookDepartment of Medical Sciences, Molecular Epidemiology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-1830-2432
Indumathi ChennamsettyDepartment of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Marcus SeldinDepartment of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-8026-4759
Xiang ZhouDepartment of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Panjamaporn SangwungDepartment of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-8145-7947
Michael J GloudemansDepartment of Genetics, Stanford University, California, CA, USA.ORCID http://orcid.org/0000-0002-9924-9943
Mark KellerDepartment of Biochemistry, University of Wisconsin, Madison, WI, USA.
Allan AttieDepartment of Biochemistry, University of Wisconsin, Madison, WI, USA.ORCID http://orcid.org/0000-0002-0568-2261
Jing YangDepartment of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, USA.ORCID http://orcid.org/0000-0002-4983-1660
Martin WabitschDivision of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, University of Ulm, Ulm, Germany.
Ivan Carcamo-OriveDepartment of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-8823-4925
Yuko TadaDepartment of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-1410-9894
Aldons J LusisDepartment of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-9013-0228
Myung Kyun ShinGenetics and Pharmacogenomics, Merck & Co., Inc., Kenilworth, NJ, USA.
Cliona M MolonyGenetics and Pharmacogenomics, Merck & Co., Inc., Kenilworth, NJ, USA.
Tracey McLaughlinStanford Diabetes Research Center, Stanford University, Stanford, CA, USA.
Gerald ReavenDepartment of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Stephen B MontgomeryStanford Diabetes Research Center, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-5200-3903
Dermot ReillyGenetics and Pharmacogenomics, Merck & Co., Inc., Kenilworth, NJ, USA.ORCID http://orcid.org/0000-0002-9456-1364
Thomas QuertermousDepartment of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-7645-9067
Erik IngelssonDepartment of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA. eriking@stanford.edu.ORCID http://orcid.org/0000-0003-2256-6972
Joshua W KnowlesDepartment of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA. knowlej@stanford.edu.ORCID http://orcid.org/0000-0003-1922-7240
Cardiovascular Institute of the South · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USStanford University · USUniversity of California, Los Angeles · USUniversity of Wisconsin–Madison · USStanford Medicine · USUniversität Ulm · DEUniversity of Illinois Urbana-Champaign · USUppsala University · SE

Funding

POSTDOCTORAL TRAINING IN MEDICAL INFORMATION SCIENCEST15LM007033 · NLM · STANFORD UNIVERSITY · PI SYLVIA KATINA PLEVRITIS · 1985 to 2026
$25.5M
Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
The Diversity Outbred Diabetes ProjectR01DK101573 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI Alan D Attie · 2014 to 2026
$5.3M
Maternal control of germline developmentR35GM131810 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Jing Yang · 2019 to 2026
$3.2M
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studiesR01DK120565 · NIDDK · STANFORD UNIVERSITY · PI KNOWLES, JOSHUA WILEY · 2019 to 2023
$3.2M
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial DysfunctionR01DK116750 · NIDDK · STANFORD UNIVERSITY · PI KNOWLES, JOSHUA WILEY · 2019 to 2023
$2.4M
Beyond GWAS of insulin resistance: An integrated approach to translate genetic association to functionR01DK106236 · NIDDK · STANFORD UNIVERSITY · PI KNOWLES, JOSHUA WILEY · 2016 to 2020
$2.4M
Molecular Mechanisms of Insulin Resistance Associated LociR01DK107437 · NIDDK · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2016 to 2019
$2.2M
NIDDK NIH HHS P30 DK116074NIDDK NIH HHS R01 DK101573NIDDK NIH HHS R01 DK106236NIDDK NIH HHS R01 DK107437NIDDK NIH HHS R01 DK116750NIDDK NIH HHS R01 DK120565NIGMS NIH HHS R35 GM131810NLM NIH HHS T15 LM007033
6 · The paper itself

Abstract

Genetic variation in the FAM13A (Family with Sequence Similarity 13 Member A) locus has been associated with several glycemic and metabolic traits in genome-wide association studies (GWAS). Here, we demonstrate that in humans, FAM13A alleles are associated with increased FAM13A expression in subcutaneous adipose tissue (SAT) and an insulin resistance-related phenotype (e.g. higher waist-to-hip ratio and fasting insulin levels, but lower body fat). In human adipocyte models, knockdown of FAM13A in preadipocytes accelerates adipocyte differentiation. In mice, Fam13a knockout (KO) have a lower visceral to subcutaneous fat (VAT/SAT) ratio after high-fat diet challenge, in comparison to their wild-type counterparts. Subcutaneous adipocytes in KO mice show a size distribution shift toward an increased number of smaller adipocytes, along with an improved adipogenic potential. Our results indicate that GWAS-associated variants within the FAM13A locus alter adipose FAM13A expression, which in turn, regulates adipocyte differentiation and contribute to changes in body fat distribution.

Indexed as

Body Fat DistributionAdipocytesAdipogenesisAnimalsCell DifferentiationGene Knockdown TechniquesGenetic LociGenome-Wide Association StudyGTPase-Activating ProteinsHEK293 CellsHumansInsulin ResistanceIntra-Abdominal FatMaleMetabolomicsMice, Inbred C57BLFAM13A protein, humanFam13a protein, mouseGTPase-Activating ProteinsRNA, Messenger

Identifiers

PMID32193374
PMCPMC7081215
OpenAlexW3011660090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.